NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC), a medical technology company specializing in neurological disorder treatments, will announce its fiscal second quarter 2025 financial results on May 13, 2025, before market open. The company will host an investor conference call and webcast at 8:30 a.m. Eastern time the same day.
Management will discuss Q2 financial results, provide corporate updates, and hold a Q&A session. The conference call can be accessed via U.S. toll-free number (888-506-0062) or international number (973-528-0011) using participant code 655933. A playback will be available until May 27, 2025, through domestic (877-481-4010) and international (919-882-2331) numbers with replay passcode 52404.
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC), un'azienda di tecnologia medica specializzata nei trattamenti per disturbi neurologici, annuncerà i suoi risultati finanziari del secondo trimestre fiscale 2025 il 13 maggio 2025, prima dell'apertura del mercato. La società terrà una conferenza telefonica per gli investitori e una webcast alle 8:30 del mattino, ora orientale dello stesso giorno.
Il management discuterà i risultati finanziari del secondo trimestre, fornirà aggiornamenti aziendali e risponderà alle domande. La conferenza telefonica sarà accessibile tramite il numero verde statunitense (888-506-0062) o il numero internazionale (973-528-0011) utilizzando il codice partecipante 655933. Una registrazione sarà disponibile fino al 27 maggio 2025, tramite i numeri nazionali (877-481-4010) e internazionali (919-882-2331) con il codice di replay 52404.
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC), una empresa de tecnología médica especializada en tratamientos para trastornos neurológicos, anunciará sus resultados financieros del segundo trimestre fiscal 2025 el 13 de mayo de 2025, antes de la apertura del mercado. La compañía realizará una llamada de conferencia para inversores y una transmisión web a las 8:30 a.m., hora del Este ese mismo día.
La dirección discutirá los resultados financieros del segundo trimestre, proporcionará actualizaciones corporativas y llevará a cabo una sesión de preguntas y respuestas. La llamada de conferencia se podrá acceder a través del número gratuito en EE. UU. (888-506-0062) o el número internacional (973-528-0011) usando el código de participante 655933. Una reproducción estará disponible hasta el 27 de mayo de 2025, mediante los números nacionales (877-481-4010) e internacionales (919-882-2331) con el código de repetición 52404.
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC)는 신경계 질환 치료를 전문으로 하는 의료 기술 회사로서, 2025 회계연도 2분기 재무 실적을 2025년 5월 13일 시장 개장 전에 발표할 예정입니다. 같은 날 동부 표준시 오전 8시 30분에 투자자 컨퍼런스 콜과 웹캐스트를 진행합니다.
경영진은 2분기 재무 실적을 논의하고 회사 업데이트를 제공하며 질의응답 시간을 가질 예정입니다. 컨퍼런스 콜은 미국 무료 전화번호(888-506-0062) 또는 국제 전화번호(973-528-0011)를 통해 참가 코드 655933를 사용하여 접속할 수 있습니다. 재생은 2025년 5월 27일까지 국내(877-481-4010) 및 국제(919-882-2331) 번호를 통해 재생 코드 52404로 이용 가능합니다.
NeuroOne Medical Technologies Corporation (NASDAQ : NMTC), une entreprise de technologie médicale spécialisée dans les traitements des troubles neurologiques, annoncera ses résultats financiers du deuxième trimestre fiscal 2025 le 13 mai 2025, avant l'ouverture des marchés. La société tiendra une conférence téléphonique et une diffusion en direct à 8h30, heure de l'Est le même jour.
La direction discutera des résultats financiers du deuxième trimestre, fournira des mises à jour sur l'entreprise et tiendra une séance de questions-réponses. La conférence téléphonique sera accessible via le numéro vert américain (888-506-0062) ou le numéro international (973-528-0011) en utilisant le code participant 655933. Une rediffusion sera disponible jusqu'au 27 mai 2025, via les numéros nationaux (877-481-4010) et internationaux (919-882-2331) avec le code de replay 52404.
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC), ein Medizintechnikunternehmen, das sich auf die Behandlung neurologischer Erkrankungen spezialisiert hat, wird seine Finanzergebnisse für das zweite Geschäftsjahrquartal 2025 am 13. Mai 2025 vor Markteröffnung bekanntgeben. Am selben Tag findet um 8:30 Uhr Eastern Time eine Telefonkonferenz und ein Webcast für Investoren statt.
Das Management wird die Finanzergebnisse des zweiten Quartals besprechen, Unternehmensupdates geben und eine Fragerunde abhalten. Die Telefonkonferenz ist über die gebührenfreie US-Nummer (888-506-0062) oder die internationale Nummer (973-528-0011) mit dem Teilnehmercode 655933 zugänglich. Eine Wiedergabe ist bis zum 27. Mai 2025 über die nationale Nummer (877-481-4010) und die internationale Nummer (919-882-2331) mit dem Wiedergabecode 52404 verfügbar.
- None.
- None.
EDEN PRAIRIE, Minn., May 01, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal second quarter ended March 31, 2025, before market open on May 13, 2025.
Management will host an investor conference call and webcast at 8:30 a.m. Eastern time on Tuesday, May 13, 2025, to discuss the Company’s second quarter fiscal year 2025 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:
Second Quarter 2025 Earnings Conference Call
Date: Tuesday, May 13, 2025
Time: 8:30 a.m. Eastern time
U.S. Dial-In (Toll Free): 888-506-0062
International Dial-In: 973-528-0011
Participant Access Code: 655933
Webcast: 2Q25 Webcast Link
Please join at least five minutes before the start of the call to ensure timely participation.
A playback of the call will be available through Tuesday, May 27, 2025. To listen, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 52404. A webcast replay will also be available using the webcast link above through May 27, 2025.
About NeuroOne
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.
IR Contact
MZ Group – MZ North America
NMTC@mzgroup.us
FAQ
When will NeuroOne (NMTC) report its Q2 2025 earnings?
How can investors access NMTC's Q2 2025 earnings call?
Until when will the replay of NeuroOne's Q2 2025 earnings call be available?
What period does NeuroOne's Q2 2025 earnings report cover?
